Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Phase II SBIR grant for preclinical work on Panacea's stroke drug

June 27, 2006

Pharmacokinetic and clinical studies of the insomnia treatment gaboxadol presented

June 27, 2006

Recent patents disclose new therapeutic agents for psychological disorders

June 26, 2006

FDA approval for extended- and immediate-release oxymorphone hydrochloride

June 26, 2006

Corgentech changes name to Anesiva

June 26, 2006

Istradefylline shows potential in restless legs syndrome

June 26, 2006

XP-13512 improves restless legs syndrome symptoms in polysomnography trial

June 26, 2006

Lundbeck to advance Lu-AA21004 for depression

June 23, 2006

Schering AG acquires Celera Genomics' cathepsin S inhibitor program

June 23, 2006

VEC-162: rapidly shifts circadian phases to improve sleep properties

June 23, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...